Michael DeLuca, PharmD, MBA, MSRA
Executive Vice President of Global Medical Affairs & Medical Information
Expertise:
Mike currently serves as Senior Vice President of Medical affairs at EVERSANA. With 20+ years of healthcare and pharmaceutical industry experience in multiple leadership roles, he holds extensive experience in medical information, medical communications, medical affairs operations, and supporting the medical review of promotional and non-promotional materials. Mike has supported the launch of 10 new products while working at multiple pharmaceutical companies and has expertise across multiple therapeutic areas, including rare disease. Mike is also a Board Member of phactMI.
Articles by Michael DeLuca, PharmD, MBA, MSRA
The Strategic Value of Medical & Scientific Fact-Checking in Medical, Legal and Regulatory Review
In today’s highly regulated pharmaceutical industry, promotional and non-promotional materials must meet the highest standards of scientific accuracy, compliance, and trust. With growing scrutiny from regulators, healthcare professionals, and the public, fact-checking has become a strategic imperative, not just a compliance checkbox. Our latest white paper, “The Strategic Value of Medical & Scientific Fact-Checking in […]
Content Evolution: Shifting to Component-Based Authoring and Modular Strategies
The pharmaceutical industry is experiencing a major transformation in how Medical Affairs teams create and share content with healthcare professionals and patients. Gone are the days of static, one-size-fits-all materials. Today, organizations are embracing component-based authoring and modular strategies—think reusable blocks like medical statements, graphs, and visuals that can be quickly assembled and tailored for […]
Interpretation of the Europe Regulatory Framework and Best Practices for MI Across the Pharma Industry
Navigating the European regulatory landscape for Medical Information (MI) is no easy feat. Recent research reveals that MI teams across pharma companies—large and small—face a patchwork of requirements and best practices, from consent handling and call recording to language support and patient access. Most organizations rely on contact center service providers and strive to cover […]
One Team, One Voice: The Impact of Centralized Medical Content Development
Featured Study – One Team, One Voice The Impact of Centralized Medical Content Development Presented at MAPS 2025. Objective: A survey was conducted to better understand Medical Affairs (MA) professionals’ strategies for medical content development, utilizing centralized versus decentralized medical content creation, and assess the adoption of structured authoring and AI-enabled solutions to improve scalability, […]
Enhancing Medical Strategies Through Effective Literature Surveillance
Members from EVERSANA’s Medical Affairs (MA) team conducted a comprehensive survey to understand the needs of MA professionals regarding literature surveillance, reviews and alerts. They presented their findings at the DIA Medical Affairs and Scientific Communications Forum in March 2025. Their survey was distributed to MA professionals via LinkedIn and covered various topics related to […]
Revolutionizing Customer Experience: The Role of AI in Enhancing MI Contact Center Operations
At the 2025 DIA Medical Affairs and Scientific Communications Forum, experts from EVERSANA gave a presentation on the transformative role of AI in enhancing Medical Information (MI) Contact Center operations and its primary objective – to improve customer experience and operational efficiency within the pharmaceutical industry through the integration of AI and advanced automation. The […]
The Evolving Landscape of HCP Engagement and the Role of Medical Information in This Era of Digital Innovation
This poster delves into the dynamic landscape of HCP engagement and the pivotal role of Medical Information (MI). It underscores the significance of effective HCP engagement for enhancing clinical decision-making and patient outcomes and emphasizes the cruciality of access to short, reliable, and personalized content across diverse digital channels and independent websites. To address these […]
Considerations for the Development of Interactive / Innovative Medical Information Content – Insights from a Service Provider
The creation of high-quality, customer-centric medical information (MI) content accessible through various data dissemination channels is crucial. EVERSANA, a provider of global MI contact center services, has embarked on developing more interactive MI content. This initiative involves converting traditional SRDs and FAQs into engaging and innovative formats by identifying considerations essential for this format of […]
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope of traditional MI services. EVERSANA conducted a survey in 2023 to assess current trends and to better understand Medical […]
Considerations for Globalization of Medical Information Services: A Service Partner Perspective
This poster details the considerations for globalizing medical information (MI) services. Traditionally, pharmaceutical companies began in one geographical region before expanding, but evolving regulations and research priorities for rare diseases, oncology/hematology, immunology, and cell and gene therapy have led to simultaneous global regulatory filings. To streamline operations and maintain control, these companies partner with global […]
Significance of Promotional and Non-Promotional Materials Review Support Services
Importance of a Well-Defined Medical Legal Regulatory Review Process It is critical for companies to have a well-defined medical, legal and regulatory review process. One of the predominant challenges companies face is that medical and regulatory reviewers often have multiple competing responsibilities. Additionally, the volumes of materials required for review can fluctuate and be significant, […]
Patient-centric Approach to Clinical Trial Support Leveraging Medical Information Services
The number of clinical studies conducted has steadily shown a significant increase year over year for the past two decades. However, the number of new drug and biologic approvals have not seen this same kind of increase. This causes several challenges for manufacturers such as increased competition and difficulty recruiting patients, particularly for rare diseases, […]
Value Proposition of Medical Information Services: Current Perspectives from the Industry
Medical Information (MI) is an important customer facing function of pharmaceutical companies that plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients and caregivers and ensuring pharmaceutical products’ safe and effective use. However, demonstrating the value of MI both internally and externally can be a challenge for many pharmaceutical company MI […]